ExpressionEdits

Protein production through genetic innovation.

Edited:

📋 Overview of ExpressionEdits

Founding Year

2021

Estimated Funding

$0000

Size

$0000

Locations

Primary Industry

Biotechnology, Industry

📙 About ExpressionEdits

ExpressionEdits offers protein production through its AI-driven genetic syntax engine and intronization technology. It unlocks the expression of previously hard-to-produce proteins for therapeutic applications. This approach enables higher yields without altering the core genetic designs, overcoming challenges that traditional methods couldn’t solve. It makes breakthroughs in gene therapy and protein therapeutics, offering solutions for medical needs once thought unattainable.

💰 Recent Investors of ExpressionEdits

Acequia Capital, Amino Capital, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.